Replies to post #535983 on NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

How rare is glioblastoma UK?

It is the most common primary brain tumour in adults, with around 2,500 cases diagnosed every year in the UK.

https://www.brainresearchuk.org.uk/research-project/brain-tumours-targeted-immunotherapy-of-glioblastoma-richard-baugh
at $150,000 that is $375 million in annual revenue
at $200,000 that is $500 million

[hope4patients]

Of course I’m aware. If it works on the worst form of brain cancer how do you think it does against less severe forms? Off label use or speedy approval. Patients and their physicians will demand it. No side effects!